An open label double arm controlled clinical study of viddhakarma & pathyadi kwatha in the management of Ardhavabhedaka (Migraine )
试验速览
- 阶段
- 2/3 期
- 状态
- 尚未招募
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- Migraine
研究概览
简要总结
It is a randomized open label double arm controlledclinical study to compare the efficacy of Viddha karma during pain phase followed by which oraladministration of Pathyadi kwata 48ml in 2 divided dose for 2 weeks andAgnikarma during pain phase followed by withwhich oral administration of Pathyadikwata 48ml in 2 divided dose for 2 weeksArdhavabhedaka ( Migraine ) conducted in single center.
研究设计
- 研究类型
- Interventional
- 分配方式
- Not Applicable
- 盲法
- Open Label
入排标准
- 年龄范围
- 20.00 Year(s) 至 45.00 Year(s)（—）
- 性别
- All
入选标准
- •1.Patients between 20-45 years of age irrespective of sex, religion, occupation and socio -economic status and willing to participate and provide consent will be included 2.Patient having minimum of one episode of headache in 7 days 3.Patients with signs and symptoms of Ardhavabhedaka and migraine 4.Patients attending OPD during Vegavastha of Ardhavabhedaka (Pain Phase of Migraine).
排除标准
- •1.Patients contraindicated for Agnikarma and Raktha mokshana as per classics.
- •2.Patients with other primary headache like tension, cluster headache
- •Patients associated with secondary headache due to Glaucoma, Frontal sinusitis.
- •4.Patients with Systemic disorders ( Diabetes Mellitus, Hypertension).
结局指标
主要结局
Migraine
时间窗: one month
4.Improvement changes in Midas
时间窗: one month
Questionnaire
时间窗: one month
3.Sustained effect of treatment in
时间窗: one month
5.A cost effective procedure which can be easily practiced
时间窗: one month
during pain phase
时间窗: one month
1.Improvement in the Subjective
时间窗: one month
and objective parameters
时间窗: one month
2.Improvementinthe HIT-6
时间窗: one month
reducingtheepisodesof
时间窗: one month
次要结局
未报告次要终点